Gainers
- Cerus, Inc. CERS stock moved upwards by 9.3% to $5.90 during Friday's pre-market session. The market value of their outstanding shares is at $511.9 million. The most recent rating by Stephens & Co., on August 23, is at Overweight, with a price target of $8.00.
- Obalon Therapeutics, Inc. OBLN shares moved upwards by 4.1% to $2.30. The market cap stands at $42.3 million.
- Viveve Medical, Inc. VIVE shares rose 2.7% to $0.13. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
Losers
- Jaguar Health, Inc. JAGX stock fell 6.8% to $1.10 during Friday's pre-market session. The market value of their outstanding shares is at $9.3 million.
- TrovaGene, Inc. TROV shares decreased by 5.1% to $2.25.
- Novavax, Inc. NVAX stock declined 3.5% to $6.40.
- Seelos Therapeutics, Inc. SEEL stock declined 2.8% to $1.73. The market value of their outstanding shares is at $60.8 million.
- CannTrust Holdings, Inc. CTST shares declined 2.1% to $1.89. The market cap stands at $320.7 million.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.